Form 4 holding
Chief Medical Officer
Ocugen, Inc.
- Security class
- Common Stock
- Shares / value
- 1,643
- Estimated value
- $1,073
- Report date
- 18 Mar 2024
- Price
- $0.6530
- Ownership
- Direct
Huma Qamar
Insider Reports History
- Reporting-owner location
- Malvern, PA
- Latest reporting-owner signature
-
/s/ Huma Qamar by Shankar Musunuri, her attorney-in-fact
Source: Latest parsed Forms 3/4/5 signature
- Transaction source note
- Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
Names, identifiers, and filing context for this profile.
1 identity field
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Reported holdings for Huma Qamar
Form 4 holding
Chief Medical Officer
Ocugen, Inc.
- Security class
- Option (Right to Buy)
- Shares / value
- 1,145,468
- Estimated value
- Report date
- 02 Jan 2025
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Chief Medical Officer
Ocugen, Inc.
- Security class
- Option (Right to Buy)
- Shares / value
- 308,465
- Estimated value
- Report date
- 16 Apr 2024
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Insider Reports Filed by Huma Qamar
4
OCGN
Ocugen, Inc.
- Report period
- 02 Jan 2025
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 06 Jan 2025, 17:01
- Role
- Chief Medical Officer
- Next action
- Open filing details
4
OCGN
Ocugen, Inc.
- Report period
- 16 Apr 2024
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 17 Apr 2024, 17:41
- Role
- Chief Medical Officer
- Next action
- Open filing details
3
OCGN
Ocugen, Inc.
- Report period
- 18 Mar 2024
- Transactions
- 0
- Transaction value
- $0
- Accepted by SEC
- 20 Mar 2024, 18:08
- Role
- Chief Medical Officer
- Next action
- Open filing details